Literature DB >> 9371829

Overexpressed human CD44s promotes lung colonization during micrometastasis of murine fibrosarcoma cells: facilitated retention in the lung vasculature.

P Kogerman1, M S Sy, L A Culp.   

Abstract

Normally nonmetastatic murine sis-transformed BALB/c 3T3 cells, transfected with human CD44s gene (hCD44s), acquire spontaneous metastatic capacity to the lung. The mechanism(s) of this facilitated micrometastasis was analyzed in an experimental metastasis model. Human CD44s overexpression promoted the earliest stages severalfold (initial implantation and subsequent stabilization of tumor cells) but was irrelevant for later stages (subsequent outgrowth) of lung experimental micrometastasis. By injecting mixed populations of parental (nonmetastatic) and CD44s-transfected cells, it was shown that cell-cell adhesion between tumor and parental cells was not promoted by hCD44s but that promotion of cell-cell adhesion to lung endothelium or specifically between transfected cells (via hyaluronan) are likely mechanisms. Results obtained with hCD44s-negative primary tumor cells and hCD44s-positive or -negative variants of lung micrometastatic cells (after s.c. injection of transfectants) confirmed the importance of CD44s overexpression for early but not late stages of experimental lung metastasis. Therefore, CD44s represents a metastasis-facilitating molecule that is irrelevant for primary tumor outgrowth but that promotes micrometastasis to the lungs at the very earliest stages.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371829      PMCID: PMC24292          DOI: 10.1073/pnas.94.24.13233

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Upregulation of CD44s in c-sis-transformed balb/c 3T3 cells by autocrine growth factor mechanisms, including PDGF.

Authors:  P Kogerman; M Sy; L Culp
Journal:  Int J Oncol       Date:  1997-03       Impact factor: 5.650

2.  Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine.

Authors:  I J Fidler
Journal:  J Natl Cancer Inst       Date:  1970-10       Impact factor: 13.506

3.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

Authors:  U Günthert; M Hofmann; W Rudy; S Reber; M Zöller; I Haussmann; S Matzku; A Wenzel; H Ponta; P Herrlich
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

4.  Expression of the CD44 glycoprotein (lymphocyte-homing receptor) in untreated human breast cancer and its relationship to prognostic markers.

Authors:  M de la Torre; P Heldin; J Bergh
Journal:  Anticancer Res       Date:  1995 Nov-Dec       Impact factor: 2.480

5.  Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model.

Authors:  P Kogerman; M S Sy; L A Culp
Journal:  Oncogene       Date:  1997-09-18       Impact factor: 9.867

6.  Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.

Authors:  Y J Guo; J Ma; J H Wong; S C Lin; H C Chang; M Bigby; M S Sy
Journal:  Cell Immunol       Date:  1993-11       Impact factor: 4.868

Review 7.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

8.  Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.

Authors:  H P Sinn; K H Heider; P Skroch-Angel; G von Minckwitz; M Kaufmann; P Herrlich; H Ponta
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

9.  Distinct effects of two CD44 isoforms on tumor growth in vivo.

Authors:  M S Sy; Y J Guo; I Stamenkovic
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway.

Authors:  H C DeGrendele; P Estess; L J Picker; M H Siegelman
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  2 in total

1.  Significance of VLA-4-VCAM-1 interaction and CD44 for transendothelial invasion in a bone marrow metastatic myeloma model.

Authors:  T Okada; R G Hawley; M Kodaka; H Okuno
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

Review 2.  Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis.

Authors:  D R Welch; P S Steeg; C W Rinker-Schaeffer
Journal:  Breast Cancer Res       Date:  2000-07-21       Impact factor: 6.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.